BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 542209)

  • 21. [Skin reactions with ubiquitous multiple antigens as a test of survival in patients with inoperable bronchogenic carcinoma].
    Giorgis GE; Oliaro A; Galietti F; Barberis S; Ardizzi A; Gallo E; Onoscuri E
    Minerva Med; 1988 Jun; 79(6):447-9. PubMed ID: 3380311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin content in the bronchial washings of patients with benign and malignant pulmonary disease.
    Mandel MA; Dvorak KJ; Worman LW; DeCosse JJ
    N Engl J Med; 1976 Sep; 295(13):694-8. PubMed ID: 958243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum immunoglobulin (IgG, IgM, IgA) levels in patients with primary brain tumors (author's transl)].
    Nakao S; Terano M; Yamashita J; Handa H
    No To Shinkei; 1977 Sep; 29(9):1005-9. PubMed ID: 921855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R; Stark M; Idel H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the results of radiotherapy in planocellular bronchial carcinoma].
    Nagorni-Obradović L
    Plucne Bolesti; 1991; 43(1-2):26-9. PubMed ID: 1766981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The surgery of non-small-cell bronchogenic carcinoma in stage IIIA. An analysis of 150 treated cases].
    Briccoli A; Gelmini R; Spallanzani A; Guernelli N
    Minerva Chir; 1999 Apr; 54(4):219-23. PubMed ID: 10380519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidermoid bronchogenic carcinoma in young adult patients].
    Azzena GF; Cavallini G; Lodi M
    Minerva Chir; 1987 Jun; 42(11):991-3. PubMed ID: 3627509
    [No Abstract]   [Full Text] [Related]  

  • 28. C1q binding activity in the sera of patients with chronic lung diseases.
    Cooper KM; Moore M; Hilton AM
    Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunocytology of cancer.
    Davidsohn I; Ni LY
    Acta Cytol; 1970 May; 14(5):276-82. PubMed ID: 4935158
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic evaluation of tracheobronchial reconstruction for bronchogenic carcinoma.
    Fujimura S; Kondo T; Imai T; Yamauchi A; Handa M; Okabe T; Nakada T
    J Thorac Cardiovasc Surg; 1985 Aug; 90(2):161-6. PubMed ID: 2991667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L; Tsougranis A
    Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulins and complement components in patients with lung cancer.
    Oner F; Savaş I; Numanoğlu N
    Tuberk Toraks; 2004; 52(1):19-23. PubMed ID: 15143368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoprofile studies for patients with bronchogenic carcinoma. I. Correlation of pretherapy studies with survival.
    Liebler GA; Concannon JP; Magovern GJ; Dalbow MH; Hodgson SE
    J Thorac Cardiovasc Surg; 1977 Oct; 74(4):506-18. PubMed ID: 302883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-specific immunostimulation in bronchogenic cancer.
    Israel L
    Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
    [No Abstract]   [Full Text] [Related]  

  • 35. Bronchogenic cancer associated with head and neck tumors. Survival analysis of 194 patients.
    Massard G; Roeslin N; Jung GM; Dumont P; Wihlm JM; Morand G
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):218-27. PubMed ID: 8393506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-associated immunoglobulins in pulmonary carcinoma.
    Gerstl B; Eng LF; Bigbee JW
    Cancer Res; 1977 Dec; 37(12):4449-55. PubMed ID: 200349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Survival in primary bronchial cancer].
    Bouacha H; Maalej M; Fourati M; Helioui MR; Nacef T
    Tunis Med; 1986 Oct; 64(10):813-7. PubMed ID: 3029928
    [No Abstract]   [Full Text] [Related]  

  • 38. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
    Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H
    Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of surgical therapeutic effects in 135 cases of early bronchogenic lung cancer].
    Xu QM
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):134-7. PubMed ID: 8223019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased circulating T alpha lymphocyte population in bronchogenic and colonic carcinoma.
    Pucci A; Clancy RL; Doe WF
    Clin Exp Immunol; 1981 Oct; 46(1):130-3. PubMed ID: 6978211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.